3BPM
Crystal Structure of Falcipain-3 with Its inhibitor, Leupeptin
Summary for 3BPM
Entry DOI | 10.2210/pdb3bpm/pdb |
Related | 1AIM 1YVB 2GHU 3BPF |
Related PRD ID | PRD_000216 |
Descriptor | Cysteine protease falcipain-3, Leupeptin, SULFATE ION, ... (4 entities in total) |
Functional Keywords | falcipain, malaria, cysteine protease, hydrolase-hydrolase inhibitor complex, hydrolase/hydrolase inhibitor |
Biological source | Plasmodium falciparum More |
Total number of polymer chains | 4 |
Total formula weight | 56090.63 |
Authors | kerr, I.D.,Lee, J.H.,Brinen, L.S. (deposition date: 2007-12-18, release date: 2008-12-30, Last modification date: 2024-11-20) |
Primary citation | Kerr, I.D.,Lee, J.H.,Pandey, K.C.,Harrison, A.,Sajid, M.,Rosenthal, P.J.,Brinen, L.S. Structures of falcipain-2 and falcipain-3 bound to small molecule inhibitors: implications for substrate specificity. J.Med.Chem., 52:852-857, 2009 Cited by PubMed Abstract: Falcipain-2 and falcipain-3 are critical hemoglobinases of Plasmodium falciparum, the most virulent human malaria parasite. We have determined the 2.9 A crystal structure of falcipain-2 in complex with the epoxysuccinate E64 and the 2.5 A crystal structure of falcipain-3 in complex with the aldehyde leupeptin. These complexes represent the first crystal structures of plasmodial cysteine proteases with small molecule inhibitors and the first reported crystal structure of falcipain-3. Our structural analyses indicate that the relative shape and flexibility of the S2 pocket are affected by a number of discrete amino acid substitutions. The cumulative effect of subtle differences, including those at "gatekeeper" positions, may explain the observed kinetic differences between these two closely related enzymes. PubMed: 19128015DOI: 10.1021/jm8013663 PDB entries with the same primary citation |
Experimental method | X-RAY DIFFRACTION (2.5 Å) |
Structure validation
Download full validation report